美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Correvio Pharma Corp.

0.4199

0.0000

成交量：- -

成交额：- -

市值：2,779.38万

市盈率：-0.53

高：0.4199

开：0.4199

低：0.4199

收：0.4199

52周最高：2.79

52周最低：0.2100

股本：6,619.15万

流通股本：6,501.11万

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.7947

每股收益(LYR):-0.7947

净资产收益率：-1158.13%

总资产收益率：-28.95%

市净率：18.07

市盈率(LYR):-0.53

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Correvio Pharma Corp.

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.correvio.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Correvio Pharma Corp.是根据公司法（不列颠哥伦比亚省）于1986年12月12日在Nortran资源有限公司的名义下注册成立。 Cardiome制药公司是一家生物制药公司，致力于改善世界各地患者的健康新疗法的发现、开发和商业化。公司拥有一个产品，BRINAVESS，在成人中快速的新近发生窦性心律的心房颤动转化，在欧洲和其他地区批准上市。公司的主导临床方案也集中在心脏的上腔治疗心房颤动上，也叫心律失常（或节律异常）。公司拥有几个临床前项目，针对各种治疗适应症，其中有一个未满足的医疗需要。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/CORV/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CORV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CORV\",,,,,undefined,":{"symbol":"CORV","market":"US","secType":"STK","nameCN":"Correvio Pharma Corp.","latestPrice":0.4199,"timestamp":1590523200000,"preClose":0.4199,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":65011067,"shares":66191487,"eps":-0.794655,"marketStatus":"停牌","change":0,"latestTime":"03-10 14:02:35 EDT","open":0.4199,"high":0.4199,"low":0.4199,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.794655,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1773172800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.4199,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CORV\",,,,,undefined,":{"symbol":"CORV","floatShares":65011067,"roa":"-28.95%","roe":"-1158.13%","lyrEps":-0.794655,"shares":66191487,"dividePrice":0,"high":0.4199,"amplitude":0,"preClose":0.4199,"low":0.4199,"week52Low":0.21,"pbRate":"18.07","week52High":2.79,"institutionHeld":0.1341,"latestPrice":0.4199,"eps":-0.794655,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.794655,"open":0.4199,"prevYearClose":0.41},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CORV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-03-30","symbol":"CORV","fiscalQuarterEnding":"2019/12","expectedEps":-0.13,"name":null,"time":"","type":"earning","dateTimestamp":1585540800000,"reportTimeType":"","actualEps":-0.1},{"date":"2019-11-14","symbol":"CORV","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/09","expectedEps":-0.17,"defaultRemindTime":1573722000000,"name":null,"time":"盘前","dateTimestamp":1573707600000,"actualEps":-0.2},{"date":"2019-08-14","symbol":"CORV","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/06","expectedEps":-0.21,"defaultRemindTime":1565769600000,"name":null,"time":"盘前","dateTimestamp":1565755200000,"actualEps":-0.37},{"market":"US","date":"2019-05-08","symbol":"CORV","fiscalQuarterEnding":"2019/03","expectedEps":-0.19,"name":null,"time":"盘前","type":"earning","dateTimestamp":1557288000000,"reportTimeType":"pre","actualEps":-0.23},{"market":"US","date":"2019-03-13","symbol":"CORV","fiscalQuarterEnding":"2018/12","expectedEps":-0.19,"name":null,"time":"盘前","type":"earning","dateTimestamp":1552449600000,"reportTimeType":"pre","actualEps":-0.18}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CORV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CORV\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.correvio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0118},{"period":"1month","weight":-0.0179},{"period":"3month","weight":-0.007},{"period":"6month","weight":0.04},{"period":"1year","weight":0.1777},{"period":"ytd","weight":-0.0054}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Correvio Pharma Corp.是根据公司法（不列颠哥伦比亚省）于1986年12月12日在Nortran资源有限公司的名义下注册成立。 Cardiome制药公司是一家生物制药公司，致力于改善世界各地患者的健康新疗法的发现、开发和商业化。公司拥有一个产品，BRINAVESS，在成人中快速的新近发生窦性心律的心房颤动转化，在欧洲和其他地区批准上市。公司的主导临床方案也集中在心脏的上腔治疗心房颤动上，也叫心律失常（或节律异常）。公司拥有几个临床前项目，针对各种治疗适应症，其中有一个未满足的医疗需要。","exchange":"NASDAQ","name":"Correvio Pharma Corp.","nameEN":"Correvio Pharma Corp."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CORV\",market:\"US\",,,undefined,":null}}